<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="del2q37_2" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">del2q37_2</book-part-id>
      <title-group>
        <title>2q37 Microdeletion Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonyms: Albright Hereditary Osteodystrophy-Like Syndrome, Brachydactyly-Mental Retardation Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Doherty</surname>
            <given-names>Emily S</given-names>
          </name>
          <xref ref-type="aff" rid="del2q37_2.AFF1"/>
          <degrees>MD, FAAP, FACMG</degrees>
          <email>esdoherty@carilionclinic.org</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Lacbawan</surname>
            <given-names>Felicitas L</given-names>
          </name>
          <xref ref-type="aff" rid="del2q37_2.AFF2"/>
          <degrees>MD, FCAP, FACMG</degrees>
          <email>lacbawf@ccf.org</email>
        </contrib>
      </contrib-group>
      <aff id="del2q37_2.AFF1">Carilion Clinic<break/>Roanoke, Virginia</aff>
      <aff id="del2q37_2.AFF2">Molecular Pathology<break/>Pathology and Laboratory Medicine Institute<break/>Cleveland Clinic<break/>Cleveland, Ohio </aff>
      <pub-history>
        <date iso-8601-date="2007-05-03" date-type="created">
          <day>03</day>
          <month>05</month>
          <year>2007</year>
        </date>
        <date iso-8601-date="2012-08-09" date-type="updated">
          <day>09</day>
          <month>08</month>
          <year>2012</year>
        </date>
        <date iso-8601-date="2013-01-31" date-type="revised">
          <day>31</day>
          <month>01</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="mdel1q21_1" document-type="chapter">1q21.1 Recurrent Microdeletion</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="gr_3ms" document-type="chapter">3-M Syndrome</related-object>
      <abstract id="del2q37_2.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>2q37 microdeletion syndrome is characterized by mild-moderate developmental delay/intellectual disability, brachymetaphalangy of digits 3-5 (often digit 4 alone) (&#x0003e;50%), short stature, obesity, hypotonia, characteristic facial appearance, autism or autism spectrum disorder (30%), joint hypermobility/dislocation, and scoliosis. Other findings include seizures (20%-35%), congenital heart disease, CNS abnormalities (hydrocephalus, dilated ventricles), umbilical/inguinal hernia, tracheomalacia, situs abnormalities, gastrointestinal abnormalities, and renal malformations. Wilms tumor has been reported in two individuals. </p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Chromosome analysis confirms the diagnosis of 2q37 deletion syndrome in 80%-85% of affected individuals. In about 15%-20% of cases the small size of the deleted region can only be detected using deletion analysis (which relies on a variety of methods). In some individuals, 2q37 microdeletion syndrome results from chromosomal rearrangements involving 2q37 (e.g., chromosome 2 inversion, ring chromosome 2, or translocation between chromosome 2 and another chromosome). Mutation of <italic toggle="yes">HDAC4</italic> has been proposed as causative for most of the features of the 2q37 microdeletion syndrome. Several affected individuals without microdeletions had inactivating mutation of <italic toggle="yes">HDAC4</italic>, a gene in the 2q37 deleted region, leading to the proposal that mutation of this gene may be causative for most of the features of the 2q37 microdeletion syndrome. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Multidisciplinary care by specialists in the following fields is often required: medical genetics, speech pathology, occupational and physical therapy, child development, neurology, cardiology, gastroenterology, nutrition/feeding, ophthalmology, and audiology. Infants benefit from enrollment in an early-intervention program; most school-age children benefit from an individualized educational program (IEP). </p>
          <p><italic toggle="yes">Surveillance:</italic> Ongoing routine primary care; periodic reevaluation by a medical geneticist to provide new recommendations and information about the syndrome; periodic neurodevelopmental and/or developmental/behavioral pediatric evaluation to assist in the management of cognitive and behavioral problems. Screening for renal cysts at age four years and again at puberty is suggested. For young children with a deletion that includes 2q37.1, screening for Wilms tumor can be considered. </p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> It is reasonable to perform genetic testing of any young child at-risk, so that Wilms tumor surveillance can be considered in those with a deletion that includes 2q37.1. </p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Most individuals with the 2q37 microdeletion syndrome have a <italic toggle="yes">de novo</italic> chromosome deletion and their parents have normal karyotypes. In approximately 5% of published cases, probands have inherited the deletion from a parent who is a balanced translocation carrier. The risk to sibs of a proband depends on the chromosome findings in the parents: the recurrence risk for future pregnancies is negligible when parental karyotypes are normal; if a parent has a balanced structural chromosome rearrangement, the risk to sibs is increased and depends on the specific chromosome rearrangement. Regarding risks to offspring: no individual with a cytogenetically visible 2q37 deletion is known to have reproduced; however, it is reasonable to expect normal fertility in mildly affected individuals with the 2q37 microdeletion syndrome. Prenatal diagnosis for pregnancies at increased risk is possible. Deletion or mutation of <italic toggle="yes">HDAC4</italic> may be inherited in an autosomal dominant manner but is more commonly <italic toggle="yes">de novo</italic>. </p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="del2q37_2.Diagnosis">
        <title>Diagnosis</title>
        <sec id="del2q37_2.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p><bold>2q37 microdeletion syndrome is suspected</bold> in individuals with the following characteristics: </p>
          <list list-type="bullet">
            <list-item>
              <p>Developmental delay/intellectual disability</p>
            </list-item>
            <list-item>
              <p>Brachymetaphalangy of digits 3-5 (often digit 4 alone), referred to as type E brachydactyly </p>
            </list-item>
            <list-item>
              <p>Short stature </p>
            </list-item>
            <list-item>
              <p>Obesity </p>
            </list-item>
            <list-item>
              <p>Hypotonia </p>
            </list-item>
            <list-item>
              <p>Characteristic facial appearance: </p>
              <list list-type="bullet">
                <list-item>
                  <p>Round face (variable) </p>
                </list-item>
                <list-item>
                  <p>Frontal bossing </p>
                </list-item>
                <list-item>
                  <p>Arched eyebrows </p>
                </list-item>
                <list-item>
                  <p>Deep-set eyes </p>
                </list-item>
                <list-item>
                  <p>Upslanted palpebral fissures </p>
                </list-item>
                <list-item>
                  <p>Epicanthal folds </p>
                </list-item>
                <list-item>
                  <p>Hypoplastic alae nasi </p>
                </list-item>
                <list-item>
                  <p>Prominent columella </p>
                </list-item>
                <list-item>
                  <p>Thin upper lip </p>
                </list-item>
                <list-item>
                  <p>Minor ear anomalies </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Autism or autism spectrum disorder </p>
            </list-item>
            <list-item>
              <p>Joint hypermobility/dislocation, scoliosis </p>
            </list-item>
          </list>
          <p>Note: When present together, the first four features (developmental delay/intellectual disability, brachymetaphalangy of digits 3-5, short stature, obesity) are often referred to as the Albright hereditary osteodystrophy (AHO)-like phenotype.</p>
          <p><bold>Other structural anomalies</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Seizures </p>
            </list-item>
            <list-item>
              <p>Congenital heart disease (atrial/ventricular septal defects, PDA) </p>
            </list-item>
            <list-item>
              <p>CNS abnormalities (hydrocephalus, dilated ventricles) </p>
            </list-item>
            <list-item>
              <p>Umbilical/inguinal hernia </p>
            </list-item>
            <list-item>
              <p>Tracheomalacia </p>
            </list-item>
            <list-item>
              <p>Situs abnormalities </p>
            </list-item>
            <list-item>
              <p>Gastrointestinal abnormalities </p>
            </list-item>
            <list-item>
              <p>Renal malformations </p>
            </list-item>
          </list>
          <p><bold>Other clinical findings</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Eczema </p>
            </list-item>
            <list-item>
              <p>Osteopenia </p>
            </list-item>
            <list-item>
              <p>Behavioral problems (hyperactivity, attention deficits) </p>
            </list-item>
          </list>
          <p><bold>Neoplasms.</bold> Wilms tumor </p>
        </sec>
        <sec id="del2q37_2.Testing">
          <title>Testing</title>
          <p><bold>Cytogenetic testing.</bold> Chromosome analysis confirms the diagnosis of 2q37 microdeletion syndrome in 80%-85% of affected individuals. </p>
          <p>In about 15%-20% of cases, the conventional karyotype is normal because of the small size of the deleted region [<xref ref-type="bibr" rid="del2q37_2.REF.shrimpton.2004.537">Shrimpton et al 2004</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.aldred.2006.635">Aldred 2006</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.lacbawan.2006.1">Lacbawan et al 2006</xref>]. 2q37 microdeletions (deletions that are not visible with routine cytogenetics) have been reported in persons with the AHO-like phenotype [<xref ref-type="bibr" rid="del2q37_2.REF.bijlsma.1999.604">Bijlsma et al 1999</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.chassaing.2004.410">Chassaing et al 2004</xref>]. Small terminal deletions of 2q may be missed on routine cytogenetic studies, and microdeletions may be undetectable unless more detailed deletion/duplication analysis is employed (<xref ref-type="table" rid="del2q37_2.T.summary_of_genetic_testing_u">Table 1</xref>: footnotes 2-4).</p>
          <p>Some individuals with the 2q37 microdeletion syndrome have chromosomal rearrangements involving 2q37, including chromosome 2 inversion, ring chromosome 2, or translocation between chromosome 2 and another chromosome that results in deletion of 2q37. </p>
          <sec id="del2q37_2.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold> The largest reported telomeric deletion in the 2q37 chromosomal region is about 10 Mb while the smallest is frequently around 3 to 4 Mb [<xref ref-type="bibr" rid="del2q37_2.REF.aldred.2006.635">Aldred 2006</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.lacbawan.2006.1">Lacbawan et al 2006</xref>]. The smallest terminal deletion reported to date was 2.7 Mb [<xref ref-type="bibr" rid="del2q37_2.REF.williams.2010.219">Williams et al 2010</xref>], although an individual with developmental delay with dysmorphic features had a paternally inherited 1.6-Mb terminal deletion [<xref ref-type="bibr" rid="del2q37_2.REF.balikova.2007.958">Balikova et al 2007</xref>]. Most likely, deletion of the genes in this chromosome region is the genetic defect known to be associated with microdeletion 2q37 syndrome. Several individuals with features of the 2q37 microdeletion syndrome have been found to have either isolated intragenic mutations of <italic toggle="yes">HDAC4</italic> or decreased <italic toggle="yes">HDAC4</italic> expression without a contiguous gene deletion, leading to the proposal that mutations in <italic toggle="yes">HDAC4</italic> are causative of most of the syndromic features of the 2q37 microdeletion syndrome [<xref ref-type="bibr" rid="del2q37_2.REF.williams.2010.219">Williams et al 2010</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.morris.2012.2015">Morris et al 2012</xref>]. See <xref ref-type="sec" rid="del2q37_2.Molecular_Genetics">Molecular Genetics</xref> for further discussion of candidate genes in the region.</p>
            <p><bold>Clinical testing</bold>
</p>
            <table-wrap id="del2q37_2.T.summary_of_genetic_testing_u" position="anchor" orientation="portrait">
              <label>Table 1.</label>
              <caption>
                <p>Summary of Genetic Testing Used in 2q37 Deletion Syndrome</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Genetic Defect in 2q37 Region</th>
                    <th id="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Mutation Detection Frequency by Test Method&#x000a0;<sup>1</sup></th>
                  </tr>
                  <tr>
                    <td headers="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">Deletion or chromosomal rearrangement involving 2q37 </td>
                    <td headers="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Cytogenetic analysis</td>
                    <td headers="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">80%-85% </td>
                  </tr>
                  <tr>
                    <td headers="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>2</sup></td>
                    <td headers="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">&#x0003e;99%&#x000a0;<sup>3,&#x000a0;4,&#x000a0;5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">HDAC4</italic> mutation in absence of 2q37 deletion/rearrangement</td>
                    <td headers="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">HDAC4</italic> sequence analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_b_del2q37_2.T.summary_of_genetic_testing_u_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Unknown, but rare</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="del2q37_2.TF.1">
                  <label>1.</label>
                  <p>The ability of the test method used to detect a mutation that is present in the indicated gene</p>
                </fn>
                <fn id="del2q37_2.TF.1.1">
                  <label>2.</label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="del2q37_2.TF.1.2">
                  <label>3.</label>
                  <p>Subtelomeric 2q probes are commercially available. A subtelomeric FISH probe should confirm the vast majority of chromosome 2q37 deletions. Theoretically, an interstitial 2q37 deletion could be missed if the subtelomeric sequence is present [<xref ref-type="bibr" rid="del2q37_2.REF.aldred.2004.433">Aldred et al 2004</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.chaabouni.2006.255">Chaabouni et al 2006</xref>].</p>
                </fn>
                <fn id="del2q37_2.TF.1.3">
                  <label>4.</label>
                  <p>Chromosomal microarray (CMA) using BAC clones confirmed a cryptic unbalanced translocation involving 2q37.2 in a spontaneously aborted fetus after cultured embryonic tissue failed to grow [<xref ref-type="bibr" rid="del2q37_2.REF.bruyere.2003.285">Bruyere et al 2003</xref>]. Most 2q37 microdeletions are detectable with commercially available CMA, although more precise mapping of the deleted region is typically performed only on a research basis [<xref ref-type="bibr" rid="del2q37_2.REF.aldred.2004.433">Aldred et al 2004</xref>; <xref ref-type="bibr" rid="del2q37_2.REF.shrimpton.2004.537">Shrimpton et al 2004</xref>; Lacbawan et al, unpublished]. </p>
                </fn>
                <fn id="del2q37_2.TF.1.4">
                  <label>5.</label>
                  <p>Although submicroscopic deletions are demonstrated using FISH or CMA, concurrent duplication/deletion may be missed by FISH study [<xref ref-type="bibr" rid="del2q37_2.REF.lacbawan.2006.1">Lacbawan et al 2006</xref>]. </p>
                </fn>
                <fn id="del2q37_2.TF.1.5">
                  <label>6.</label>
                  <p>Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="del2q37_2.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis of 2q37 microdeletion in a proband,</bold> the following testing should be performed:</p>
          <p>
            <bold>First alternative</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Deletion/duplication analysis could be performed first, as it will detect large deletions, microdeletions, and microduplications of the 2q37 region. In addition, it would screen for other microdeletion/microduplication syndromes (e.g., <related-object link-type="booklink" source-id="gene" document-id="sms" document-type="chapter">Smith-Magenis syndrome</related-object>) that have overlapping clinical features with the 2q37 microdeletion syndrome.Note: Deletion/duplication analyses (e.g., CMA) typically do not directly evaluate chromosomal structure; thus, when results suggest an unbalanced translocation or a ring chromosome, conventional cytogenetic studies are needed to confirm these structural chromosome anomalies.</p>
            </list-item>
          </list>
          <p>
            <bold>Second alternative</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>For familial cases where other chromosomal rearrangements may be present, karyotype (i.e., routine cytogenetic study) should be done.</p>
            </list-item>
            <list-item>
              <p>If the chromosome study is normal but the index of suspicion is high, targeted deletion analysis of the 2q37 region may be performed.</p>
            </list-item>
          </list>
          <p>If the proband has clinical features of the 2q37 microdeletion syndrome but no microdeletion or chromosome anomaly involving 2q37 is found on the above testing, sequence analysis of <italic toggle="yes">HDAC4</italic> could be considered.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the deletion or mutation in the proband and/or of balanced carrier status in a parent. </p>
        </sec>
      </sec>
      <sec id="del2q37_2.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="del2q37_2.Natural_History">
          <title>Clinical Description</title>
          <p>The 2q37 microdeletion syndrome may present with a broad spectrum of clinical findings as described below [<xref ref-type="bibr" rid="del2q37_2.REF.smith.2001.15">Smith et al 2001</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.casas.2004.331">Casas et al 2004</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.chassaing.2004.410">Chassaing et al 2004</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.lacbawan.2005.1">Lacbawan et al 2005</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.aldred.2006.635">Aldred 2006</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.chaabouni.2006.255">Chaabouni et al 2006</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.lacbawan.2006.1">Lacbawan et al 2006</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.kitsioutzeli.2007.73">Kitsiou-Tzeli et al 2007</xref>].</p>
          <p>In individuals with isolated microdeletion 2q37 (i.e., those without an unbalanced translocation), functional outcome was affected by the presence of autism, developmental delay, and/or major congenital anomalies.</p>
          <p>The phenotype observed in individuals with 2q37 microdeletion syndrome seems variable in earlier reports because the molecular breakpoints were not defined.</p>
          <p>The published female-to-male ratio is greater than one. </p>
          <p><bold>Developmental delay.</bold> Most affected individuals have mild-moderate developmental delay. However, one individual with delayed developmental milestones was reported to work as a librarian's assistant and a second individual was a college student with autism and average-range cognitive function. </p>
          <p><bold>Autism or autism spectrum disorder.</bold> 2q37 microdeletions are common in individuals with syndromic autism [<xref ref-type="bibr" rid="del2q37_2.REF.jacquemont.2006.843">Jacquemont et al 2006</xref>]. Approximately one third of those reported with 2q37 microdeletion syndrome have autism or autistic features, which show significant variation among individuals. Nonetheless, no behavioral phenotype appears to be specific to the 2q37 microdeletion syndrome. </p>
          <p><bold>Brachymetaphalangy.</bold> Short metacarpals/metatarsals of digits 3-5, often of digit 4 alone, are present in more than half of reported cases. No functional implications are associated with the shortened digit(s). Brachymetaphalangy may not be clinically apparent in young children, though this feature has been described in several children under age one year. </p>
          <p><bold>Growth.</bold> The incidence of short stature is increased in individuals with 2q37 microdeletion syndrome. Failure to thrive is sometimes reported in affected infants. </p>
          <p><bold>Obesity.</bold> Obesity may be noted in childhood. The prevalence of obesity appears to increase with age. </p>
          <p><bold>Hypotonia.</bold> A significant number of individuals with 2q37 microdeletion syndrome have hypotonia and feeding difficulties. Genu valgum/recurvatum and pes planus are also common. </p>
          <p><bold>Characteristic facial appearance and other dysmorphic features.</bold> The typical facial characteristics include thin, arched eyebrows with deeply set eyes, hypoplastic nares, prominent columella, thin vermilion border, and minor ear dysmorphism with or without round face. The facial phenotype can be subtle, and may not be easily recognized by less experienced clinicians. Use of stereophotogrammetry has been shown to be able to distinguish the facial phenotype. </p>
          <p>Low-set, hypoplastic nipples are often seen. Joint hyperextensibility and skin hyperlaxity may be observed.</p>
          <p><bold>Seizures</bold> of some type, including grand mal, partial, and myoclonic, have been noted in approximately 20%-35% of reported cases; very little clinical information is provided in most reports. </p>
          <p><bold>Eczema.</bold> Moderate-to-severe eczema has been reported in a few individuals. </p>
          <p><bold>Osteopenia.</bold> Though osteopenia is not well known to be associated with 2q37 deletion, a number of affected individuals have had osteopenia on further radiologic studies. Clinical implications have not been described. </p>
          <p><bold>Gastroesophageal reflux (GER).</bold> Moderate-to-severe GER can occur, and can be severe enough to necessitate surgical intervention. </p>
          <p><related-object link-type="booklink" source-id="gene" document-id="wilms-ov" document-type="chapter"><bold>Wilms tumor</bold></related-object>. Three individuals with isolated 2q37 microdeletion syndrome and Wilms tumor have been reported [<xref ref-type="bibr" rid="del2q37_2.REF.conrad.1995.134">Conrad et al 1995</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.olson.1995.305">Olson et al 1995</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.viotszoboszlai.1998.278">Viot-Szoboszlai et al 1998</xref>]. All three children presented before age two years. <xref ref-type="bibr" rid="del2q37_2.REF.olson.1995.305">Olson et al [1995]</xref> reported another individual with an unbalanced translocation der(2)t(2;15)(q37;q22) and Wilms tumor. An individual with a 46,XY,add(2)(q35) karyotype and Wilms tumor was reported by <xref ref-type="bibr" rid="del2q37_2.REF.jones.2011.2221">Jones et al [2011]</xref>. Both individuals presented between age two and age three years. However, screening of a large cohort of individuals with 2q terminal deletions did not find other individuals with Wilms tumor. Jones and colleagues estimate a 1% risk of Wilms tumor in individuals with 2q deletions. </p>
          <p><bold>Other structural anomalies</bold> [<xref ref-type="bibr" rid="del2q37_2.REF.reddy.1999.460">Reddy et al 1999</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.lehman.2001.179">Lehman et al 2001</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.aldred.2006.635">Aldred 2006</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.masumoto.2006.213">Masumoto et al 2006</xref>]: </p>
          <list list-type="bullet">
            <list-item>
              <p>Cleft palate </p>
            </list-item>
            <list-item>
              <p>Congenital hearing loss </p>
            </list-item>
            <list-item>
              <p>Congenital heart disease (typically atrial/ventricular septal defects) </p>
            </list-item>
            <list-item>
              <p>Situs abnormalities </p>
            </list-item>
            <list-item>
              <p>Renal malformations including horseshoe kidney </p>
            </list-item>
            <list-item>
              <p>CNS abnormalities including separate cases reported with holoprosencephaly, agenesis of the corpus callosum, and hydrocephalus </p>
            </list-item>
            <list-item>
              <p>Gastrointestinal abnormalities, including hiatal hernia, pyloric stenosis, malrotation, anal atresia, and esophageal atresia </p>
            </list-item>
            <list-item>
              <p>Joint hypermobility/dislocation and scoliosis </p>
            </list-item>
            <list-item>
              <p>Umbilical/inguinal hernia </p>
            </list-item>
          </list>
          <p><bold>Life span.</bold> The presence of congenital malformations appears to be the single greatest factor in determining life expectancy. Few older adults have been reported with 2q37 microdeletion syndrome; however, the authors anticipate that this will change as more individuals are ascertained with the use of subtelomeric FISH and CMA studies and longitudinal data are collected on those with the disorder. The literature continues to demonstrate that the vast majority of individuals with this syndrome do not have a shortened life span.</p>
        </sec>
        <sec id="del2q37_2.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Penetrance is complete in the 2q37 microdeletion syndrome; however, phenotypic variability is observed. Using both cytogenetic and molecular analyses, deletion size does not appear to correlate well with phenotype. Brachymetaphalangy is observed in approximately half of individuals with deletions of the Albright hereditary osteodystrophy (AHO)-like critical region containing <italic toggle="yes">HDAC4</italic> [<xref ref-type="bibr" rid="del2q37_2.REF.aldred.2004.433">Aldred et al 2004</xref>]. </p>
          <p>Further genotype-phenotype correlations have not been established. </p>
          <p>A parent-of-origin effect has not been convincingly demonstrated.</p>
        </sec>
        <sec id="del2q37_2.Penetrance">
          <title>Penetrance</title>
          <p>Clinical characteristics of 2q37 microdeletion syndrome are apparent and no case of mosaicism has been documented to date. </p>
        </sec>
        <sec id="del2q37_2.Nomenclature">
          <title>Nomenclature</title>
          <p>The 2q37 microdeletion syndrome has also been referred to as Albright hereditary osteodystrophy 3.</p>
        </sec>
        <sec id="del2q37_2.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of the 2q37 microdeletion syndrome is unknown. It is likely that this syndrome is underdiagnosed because of difficulty in recognizing the small terminal deletion on routine cytogenetic studies, and failure to recognize the clinical syndrome on physical examination. It is expected that more individuals will be diagnosed as the clinical use of subtelomeric FISH and CMA studies increases.</p>
        </sec>
      </sec>
      <sec id="del2q37_2.Genetically_Related_Allelic_Di">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>The 2q37 microdeletion syndrome may present with a broad spectrum of clinical findings. Prior to the clinical introduction of chromosomal microarray, subtelomeric FISH identified 2q37 deletions in a number of individuals referred for developmental delay/intellectual disability with or without other dysmorphic features [<xref ref-type="bibr" rid="del2q37_2.REF.anderlid.2002.275">Anderlid et al 2002</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.sogaard.2005.21">Sogaard et al 2005</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.ravnan.2006.478">Ravnan et al 2006</xref>]. The 2q37 microdeletion syndrome phenotype was not clearly described in any of these individuals. </p>
        <p>A pilot study of children with autism reported one nondysmorphic child with a normal examination and a subtelomeric deletion of 2q [<xref ref-type="bibr" rid="del2q37_2.REF.wolff.2002.10">Wolff et al 2002</xref>]. Similarly, in a large cohort of more than 400 autistic individuals, <xref ref-type="bibr" rid="del2q37_2.REF.reddy.2005.3">Reddy [2005]</xref> reported a child with autism and macrocephaly who had a 2q37 deletion identified by FISH. Further molecular characterization of these individuals would be helpful. </p>
      </sec>
      <sec id="del2q37_2.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Albright hereditary osteodystrophy (AHO)</bold> is characterized by obesity, short stature, brachydactyly, subcutaneous ossifications, and intellectual disability. Most individuals with AHO have an inactivating mutation in <italic toggle="yes">GNAS</italic>, the gene encoding the alpha subunit of a G-protein. </p>
        <list list-type="bullet">
          <list-item>
            <p>Maternally inherited mutations are associated with resistance to parathyroid hormone (PTH) (known as pseudohypoparathyroidism type 1A), thyroid stimulating hormone (TSH), and gonadotropins. </p>
          </list-item>
          <list-item>
            <p>Paternally inherited mutations are associated only with AHO (also known as pseudopseudohypoparathyroidism). </p>
          </list-item>
        </list>
        <p>The clinical overlap between AHO/pseudopseudohypoparathyroidism and the 2q37 microdeletion syndrome may be substantial [<xref ref-type="bibr" rid="del2q37_2.REF.aldred.2004.433">Aldred et al 2004</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.aldred.2006.635">Aldred 2006</xref>]. The authors are not aware of any individuals with the 2q37 microdeletion syndrome who had subcutaneous calcifications or hormone resistance, both of which can be seen in AHO.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="sms" document-type="chapter"><bold>Smith-Magenis syndrome</bold></related-object>. Phenotypic overlap with Smith-Magenis syndrome was clearly demonstrated by <xref ref-type="bibr" rid="del2q37_2.REF.williams.2010.219">Williams et al [2010]</xref>. </p>
        <p><related-object link-type="booklink" source-id="gene" document-id="kabuki" document-type="chapter"><bold>Kabuki syndrome</bold></related-object>. Two individuals with phenotypic features suspicious for Kabuki syndrome had chromosomal rearrangements that included 2q37 deletion [<xref ref-type="bibr" rid="del2q37_2.REF.cusco.2008.27">Cusco et al 2008</xref>]. </p>
        <p><related-object link-type="booklink" source-id="gene" document-id="charge" document-type="chapter"><bold>CHARGE syndrome</bold></related-object>. Two children in a family with an unbalanced translocation between 2q and 21q resulting in a 2q37 microdeletion presented with choanal atresia and were initially misdiagnosed as having CHARGE syndrome [<xref ref-type="bibr" rid="del2q37_2.REF.fernandezrebollo.2009.711">Fernandez-Rebollo et al 2009</xref>]. </p>
        <p><bold>Type E brachydactyly</bold> (metacarpal 3-5 shortening) has been described in Turner syndrome. <italic toggle="yes">HOXD13</italic> mutations have been reported in a skeletal malformation syndrome with overlap between brachydactyly types D and E [<xref ref-type="bibr" rid="del2q37_2.REF.johnson.2003.984">Johnson et al 2003</xref>]. </p>
      </sec>
      <sec id="del2q37_2.Management">
        <title>Management</title>
        <sec id="del2q37_2.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with the 2q37 microdeletion syndrome, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete medical history to include evidence of any congenital malformations, seizure disorder, or behavioral problems </p>
            </list-item>
            <list-item>
              <p>Complete physical and dysmorphology examination </p>
            </list-item>
            <list-item>
              <p>Determination of head circumference, height, weight, and other anthropometric measurements </p>
            </list-item>
            <list-item>
              <p>Specialty evaluation of obesity or failure to thrive </p>
            </list-item>
            <list-item>
              <p>Multidisciplinary developmental and neurologic evaluation to assess motor and cognitive skills as well as autism, autism spectrum behaviors, and other behavioral issues </p>
            </list-item>
            <list-item>
              <p>Echocardiogram to evaluate for congenital cardiac anomaly </p>
            </list-item>
            <list-item>
              <p>Renal ultrasound examination to evaluate for possible Wilms tumor, renal malformation, or other renal problems </p>
            </list-item>
            <list-item>
              <p>Ophthalmology evaluation for strabismus and/or refractive errors </p>
            </list-item>
            <list-item>
              <p>Audiologic assessment for possible hearing loss </p>
            </list-item>
            <list-item>
              <p>Brain imaging studies (MRI, CT scan) in individuals with abnormal neurologic findings </p>
            </list-item>
            <list-item>
              <p>EEG for evaluation of seizures and treatment monitoring </p>
            </list-item>
            <list-item>
              <p>X-ray to evaluate for the presence of scoliosis and skeletal anomalies examination. While the clinical implications of osteopenia have not been studied in the 2q37 microdeletion syndrome, clinicians should be aware that this is a common finding. x-rays should be performed at diagnosis and should be repeated as warranted by clinical examination. The youngest individual with osteopenia in the authors' series is age three years. </p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="del2q37_2.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Depending on the age and presenting concerns of the individual with the 2q37 microdeletion syndrome, care from specialists in the following areas is often necessary: medical genetics, speech pathology, occupational and physical therapy, child development, neurology, cardiology, gastroenterology, nutrition/feeding in cases of failure to thrive, ophthalmology, and audiology.</p>
          <p>Medical care may be coordinated by a medical geneticist or other health care professional skilled at managing patients with complex needs.</p>
          <p>Infants benefit from enrollment in an early-intervention program. Most school-age children benefit from an individualized educational program (IEP) with input from a multi-specialty group of physical, occupational, and speech therapists with pediatric assessment.</p>
        </sec>
        <sec id="del2q37_2.Prevention_of_Secondary_Compli">
          <title>Prevention of Secondary Complications</title>
          <p>At this time, it is not known why many individuals with the 2q37 microdeletion syndrome are obese. To the extent that it is feasible, the authors recommend an active lifestyle and good dietary habits to help avoid development of obesity.</p>
        </sec>
        <sec id="del2q37_2.Surveillance">
          <title>Surveillance</title>
          <p><xref ref-type="bibr" rid="del2q37_2.REF.jones.2011.2221">Jones et al [2011]</xref> suggested that individuals with 2q deletions sparing 2q37.1 likely have a less than 5% risk of developing Wilms tumor; therefore, they do not recommend surveillance for the development of Wilms tumor in these individuals. Wilms tumor screening can be considered for individuals with deletions including 2q37.1, although screening intervals are not delineated. Wilms tumor screening protocols in individuals with <related-object link-type="booklink" source-id="gene" document-id="aniridia" document-type="chapter">WAGR syndrome</related-object> and <related-object link-type="booklink" source-id="gene" document-id="bws" document-type="chapter">Beckwith-Wiedemann syndrome</related-object> include abdominal ultrasounds every three months until mid-childhood [<xref ref-type="bibr" rid="del2q37_2.REF.beckwith.1998.268">Beckwith 1998</xref>]. The practitioner caring for an infant or young child with a 2q37 deletion is encouraged to monitor the literature for updates.</p>
          <p>When the 2q37 microdeletion is identified in early childhood, screening for the development of renal cysts at age four years and again at puberty is suggested [<xref ref-type="bibr" rid="del2q37_2.REF.falk.2007.357">Falk &#x00026; Casas 2007</xref>].</p>
          <p>The following are also appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Ongoing routine pediatric care </p>
            </list-item>
            <list-item>
              <p>Periodic reevaluation by a medical geneticist to provide new recommendations and information about the syndrome </p>
            </list-item>
            <list-item>
              <p>Periodic neurodevelopmental and/or developmental/behavioral pediatric evaluation to assist in the management of cognitive and behavioral problems</p>
            </list-item>
          </list>
        </sec>
        <sec id="del2q37_2.Evaluation_of_Relatives_at_Ris">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is reasonable to perform genetic testing of any young child at risk, so that Wilms tumor surveillance can be considered in those with a deletion that includes 2q37.1. </p>
          <p>See <xref ref-type="sec" rid="del2q37_2.Related_Genetic_Counseling_Iss">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="del2q37_2.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder. </p>
        </sec>
      </sec>
      <sec id="del2q37_2.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="del2q37_2.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>2q37 microdeletion syndrome can be the result of a <italic toggle="yes">de novo</italic> chromosome abnormality or may be inherited from a parent who is a balanced translocation or inversion carrier. </p>
          <p>Instances of deletion or mutation of <italic toggle="yes">HDAC4</italic> may be inherited in an autosomal dominant manner but are more commonly <italic toggle="yes">de novo</italic>. </p>
        </sec>
        <sec id="del2q37_2.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Most probands have a <italic toggle="yes">de novo</italic> chromosome deletion and their parents have normal karyotypes. Familial chromosome rearrangements have been identified in approximately 5% of published cases. Some of these rearrangements are cytogenetically cryptic [<xref ref-type="bibr" rid="del2q37_2.REF.bijlsma.1999.604">Bijlsma et al 1999</xref>]. </p>
            </list-item>
            <list-item>
              <p>Most cases of deletion or mutation of <italic toggle="yes">HDAC4</italic> are <italic toggle="yes">de novo</italic>, but familial cases have been reported [<xref ref-type="bibr" rid="del2q37_2.REF.villavicenciolorini.2012.1">Villavicencio-Lorini et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Parents of a proband with a structurally unbalanced chromosome constitution (e.g., deletion or translocation) are at risk of having a balanced chromosome rearrangement and should be offered chromosome analysis. </p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs of a proband with 2q37 deletion syndrome depends on the genetic status of the parents. </p>
            </list-item>
            <list-item>
              <p>As with other <italic toggle="yes">de novo</italic> chromosome rearrangements, the recurrence risk for future pregnancies is negligible when parental karyotypes are normal. </p>
            </list-item>
            <list-item>
              <p>If a parent has a balanced structural chromosome rearrangement, the risk to sibs is increased and depends on the specific chromosome rearrangement and the possibility of other variables. </p>
            </list-item>
            <list-item>
              <p>The occurrence of germline mosaicism has not been reported in individuals with 2q37 deletion syndrome, although the possibility cannot be excluded. </p>
            </list-item>
            <list-item>
              <p>If a parent has an <italic toggle="yes">HDAC4</italic> mutation, the risk to each sib is 50%.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>To date, no individual with a cytogenetically visible 2q37 deletion has been reported to reproduce. </p>
            </list-item>
            <list-item>
              <p>An affected female with some features of the 2q37 microdeletion syndrome was born to a &#x0201c;normal&#x0201d; father with a cryptic subtelomeric deletion [<xref ref-type="bibr" rid="del2q37_2.REF.vankarnebeek.2002.546">van Karnebeek et al 2002</xref>]. Menarche was reported in an adolescent girl who subsequently experienced secondary amenorrhea [<xref ref-type="bibr" rid="del2q37_2.REF.wilson.1995.400">Wilson et al 1995</xref>], and the authors have personally examined a second female with normal menses. It is reasonable to expect normal fertility in mildly affected individuals with the 2q37 microdeletion syndrome. In this case, the risk of transmitting the chromosome deletion would be 50% for each pregnancy. </p>
            </list-item>
          </list>
          <p>
            <bold>Other family members</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the genetic status of the proband's parents. </p>
            </list-item>
            <list-item>
              <p>If a parent has a balanced chromosome rearrangement, his or her family members may be at risk and should be offered chromosome analysis and FISH. </p>
            </list-item>
          </list>
        </sec>
        <sec id="del2q37_2.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>If a parent of the proband has a balanced chromosome rearrangement, at-risk family members can be tested by chromosome analysis and/or FISH. </p>
        </sec>
        <sec id="del2q37_2.Related_Genetic_Counseling_Iss">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="del2q37_2.Evaluation_of_Relatives_at_Ris">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, mutations, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="del2q37_2.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Prenatal diagnosis for pregnancies at increased risk is possible by chromosome analysis of fetal cells obtained by amniocentesis usually performed at about 15 to 18 weeks' gestation or by chorionic villus sampling (CVS) at about ten to 12 weeks' gestation. It is difficult to visualize terminal chromosome deletions in fetal cells; therefore, confirmation of the result with FISH should be performed. </p>
          <p>Prenatal diagnosis for pregnancies at increased risk for an <italic toggle="yes">HDAC4</italic> mutation/deletion is possible by analysis of DNA extracted from fetal cells obtained by amniocentesis or chorionic villus sampling (CVS). The disease-causing mutation of an affected family member must be identified in the family before prenatal testing can be performed.</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families at increased risk for a pregnancy with 2q37 deletion syndrome or with an <italic toggle="yes">HDAC4</italic> mutation/deletion.</p>
        </sec>
      </sec>
      <sec id="del2q37_2.Resources">
        <title>Resources</title>
      </sec>
      <sec id="del2q37_2.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="del2q37_2.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Proposed candidate genes responsible for the Albright hereditary osteodystrophy (AHO)-like phenotype in individuals with 2q37 microdeletion syndrome include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="bibr" rid="del2q37_2.REF.chaabouni.2006.255">Chaabouni et al [2006]</xref> initially narrowed the critical region for the AHO-like phenotype to an approximately 2-Mb interstitial region at 2q37.3 containing <italic toggle="yes">HDAC4</italic>, <italic toggle="yes">GPC1</italic>, and <italic toggle="yes">STK25</italic>. </p>
              <list list-type="bullet">
                <list-item>
                  <p><bold><italic toggle="yes">HDAC4</italic></bold>. In 2010, Williams et al published two AHO-like cases with apparently isolated intragenic inactivating mutations of <italic toggle="yes">HDAC4</italic>. They proposed <italic toggle="yes">HDAC4</italic> as the gene in which mutation caused the syndromic features of the 2q37 microdeletion syndrome (see OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/605314">605314</ext-link> for a summary of the allelic variants identified in these two cases). Recently, an individual with a cryptic balanced translocation between chromosomes 2q37 and 10q26 was found to have mild features of the 2q37 microdeletion syndrome. <italic toggle="yes">HDAC4</italic> expression was 67% compared to expression in control individuals. This individual&#x02019;s son, who had an unbalanced translocation resulting in a 9.84 Mb deletion of 2q37.1, was found to have a more severe phenotype and 23% expression of <italic toggle="yes">HDAC4</italic> compared to control individuals [<xref ref-type="bibr" rid="del2q37_2.REF.morris.2012.2015">Morris et al 2012</xref>]. <italic toggle="yes">HDAC4</italic> has 27 exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006037.3">NM_006037.3</ext-link>) and encodes a protein of 1084 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_006028.2">NP_006028.2</ext-link>).</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Three individuals with Wilms tumor and constitutional 2q37 or 2q37.1 deletion (without other chromosome anomalies) have been reported [<xref ref-type="bibr" rid="del2q37_2.REF.conrad.1995.134">Conrad et al 1995</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.olson.1995.305">Olson et al 1995</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.viotszoboszlai.1998.278">Viot-Szoboszlai et al 1998</xref>]. Since 2q37.1 is centromeric to <italic toggle="yes">HDAC4,</italic> it is hypothesized that there is a tumor-suppressor gene at 2q37.1, and that individuals with &#x0201c;larger&#x0201d; chromosome deletions involving 2q37.1 may be at increased risk of developing Wilms tumor. <xref ref-type="bibr" rid="del2q37_2.REF.drake.2009.5985">Drake et al [2009]</xref> studied a series of sporadic Wilms tumors and found evidence of a tumor suppressor role for a 360-kb critical region containing <italic toggle="yes">DIS3L2</italic> and adjacent noncoding microRNA <italic toggle="yes">miR-562</italic>. <xref ref-type="bibr" rid="del2q37_2.REF.astuti.2012.277">Astuti et al [2012]</xref> subsequently identified <italic toggle="yes">DIS3L2</italic> mutations in individuals with Perlman syndrome, a Wilms tumor predisposition syndrome. </p>
            </list-item>
            <list-item>
              <p>Genome-wide linkage studies have shown an autism susceptibility region on 2q37 [<xref ref-type="bibr" rid="del2q37_2.REF.internationalmole.2001.570">International Molecular Genetic Study of Autism Consortium 2001</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.morrow.2008.218">Morrow et al 2008</xref>]. </p>
            </list-item>
          </list>
          <p>Proposed candidate genes responsible for the autistic features in individuals with 2q37 microdeletion syndrome include the following: </p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">KIF1A</italic>, previously known as <italic toggle="yes">ATSV</italic>, is an axonal transporter of syntaptic vesicles [<xref ref-type="bibr" rid="del2q37_2.REF.smith.2001.15">Smith et al 2001</xref>, <xref ref-type="bibr" rid="del2q37_2.REF.devillard.2010.2346">Devillard et al 2010</xref>]. </p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">FARP2</italic>, <italic toggle="yes">HDLBP</italic>, and <italic toggle="yes">PASK</italic> were identified as candidate genes because of their structural and functional relation to pathways in neuronal and skeletal pathways. All three were downregulated in an individual with a 3.5-Mb deletion and autism, compared to family members and healthy controls [<xref ref-type="bibr" rid="del2q37_2.REF.felder.2009.952">Felder et al 2009</xref>]. FARP2 is a GTPase involved in neurite growth and axonal guidance. Vigilin (high density lipoprotein &#x02013;binding protein, HDLBP) is a multi-KH-domain containing protein in cholesterol metabolism and structurally similar to FMR1 (<related-object link-type="booklink" source-id="gene" document-id="fragilex" document-type="chapter">Fragile X</related-object>); PASK (Pas-domain serine/threonine kinase) is a kinase important in normal axonal ensheathment. </p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="del2q37_2.REF.lukusa.2004.293">Lukusa et al [2004]</xref> considered <italic toggle="yes">CENTG2</italic>, now known as <italic toggle="yes">AGAP1</italic>, a candidate gene for autism. <xref ref-type="bibr" rid="del2q37_2.REF.wassink.2005.36">Wassink et al [2005]</xref> confirmed deletion of this gene in an autistic female with a cytogenetically visible 2q37 deletion, AHO-like features, and normal intelligence. <italic toggle="yes">AGAP1</italic> is expressed in the fetal and adult brain and is involved in endocytic trafficking [<xref ref-type="bibr" rid="del2q37_2.REF.nie.2002.48965">Nie et al 2002</xref>].</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="del2q37_2.References">
        <title>References</title>
        <sec id="del2q37_2.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="del2q37_2.Literature_Cited.reflist0">
            <ref id="del2q37_2.REF.aldred.2006.635">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aldred</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Genetics of pseudohypoparathyroidism types Ia and Ic.</article-title>
                <source>J Pediatr Endocrinol Metab</source>
                <year>2006</year>
                <volume>19</volume>
                <supplement>Suppl 2</supplement>
                <fpage>635</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">16789628</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.aldred.2004.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aldred</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanford</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrow</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brueton</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaglia</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dennis</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trembath</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <article-title>Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes.</article-title>
                <source>J Med Genet</source>
                <year>2004</year>
                <volume>41</volume>
                <fpage>433</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15173228</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.anderlid.2002.275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anderlid</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoumans</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anneren</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahlen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyllerman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vujic</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blennow</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordenskjold</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Subtelomeric rearrangements detected in patients with idiopathic mental retardation.</article-title>
                <source>Am J Med Genet</source>
                <year>2002</year>
                <volume>107</volume>
                <fpage>275</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">11840483</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.astuti.2012.277">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Astuti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>WN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staals</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wake</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fews</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gill</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gentle</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shuib</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricketts</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Essen</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Lingen</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rump</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stolte-Dijkstra</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruijn</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latif</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <article-title>Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.</article-title>
                <source>Nat Genet</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>277</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">22306653</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.balikova.2007.958">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balikova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menten</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Ravel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Caignec</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thienpont</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urbina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doco-Fenzy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Rademaeker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kooy</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Ende</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speleman</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeesch</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <article-title>Subtelomeric imbalances in phenotypically normal individuals.</article-title>
                <source>Hum Mutat</source>
                <year>2007</year>
                <volume>28</volume>
                <fpage>958</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">17492636</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.beckwith.1998.268">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beckwith</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <article-title>Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations.</article-title>
                <source>Am J Med Genet.</source>
                <year>1998</year>
                <volume>79</volume>
                <fpage>268</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">9781906</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.bijlsma.1999.604">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bijlsma</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aalfs</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sluitjer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oude Luttikhuis</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trembath</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoovers</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <article-title>Familial cryptic translocation between chromosomes 2qter and 8qter: further delineation of the Albright hereditary osteodystrophy-like phenotype.</article-title>
                <source>J Med Genet</source>
                <year>1999</year>
                <volume>36</volume>
                <fpage>604</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10465110</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.bruyere.2003.285">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bruyere</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajcan-Separovic</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pantzar</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langlois</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Familial cryptic translocation (2;17) ascertained through recurrent spontaneous abortions.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2003</year>
                <volume>123A</volume>
                <fpage>285</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14608651</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.casas.2004.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Casas</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mononen</surname>
                    <given-names>TK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikail</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassed</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulvihill</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falk</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <article-title>Chromosome 2q terminal deletion: report of 6 new patients and review of phenotype-breakpoint correlations in 66 individuals.</article-title>
                <source>Am J Med Genet A</source>
                <year>2004</year>
                <volume>130A</volume>
                <fpage>331</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15386475</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.chaabouni.2006.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaabouni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raoul</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prieur</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Blois</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philippe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romana</surname>
                    <given-names>SP</given-names>
                  </name>
                </person-group>
                <article-title>Molecular cytogenetic analysis of five 2q37 deletions: refining the brachydactyly candidate region.</article-title>
                <source>Eur J Med Genet</source>
                <year>2006</year>
                <volume>49</volume>
                <fpage>255</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16762827</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.chassaing.2004.410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chassaing</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Mas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tauber</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourrouillou</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bieth</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Molecular characterization of a cryptic 2q37 deletion in a patient with Albright hereditary osteodystrophy-like phenotype.</article-title>
                <source>Am J Med Genet A</source>
                <year>2004</year>
                <volume>128A</volume>
                <fpage>410</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15264288</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.conrad.1995.134">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Conrad</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dewald</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higgins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierpont</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <article-title>Clinical phenotype associated with terminal 2q37 deletion.</article-title>
                <source>Clin Genet</source>
                <year>1995</year>
                <volume>48</volume>
                <fpage>134</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">8556820</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.cusco.2008.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cusc&#x000f3;</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>del Campo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilardell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gener</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gal&#x000e1;n</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toledo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Jurado</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <article-title>Array-CGH in patients with Kabuki-like phenotype: identification of two patients with complex rearrangements including 2q37 deletions and no other recurrent aberration.</article-title>
                <source>BMC Med Genet</source>
                <year>2008</year>
                <volume>9</volume>
                <fpage>27</fpage>
                <pub-id pub-id-type="pmid">18405349</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.devillard.2010.2346">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Devillard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guinchat</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreno-De-Luca</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabet</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruchy</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillem</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen Morel</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leporrier</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leboyer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jouk</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lespinasse</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Betancur</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Paracentric inversion of chromosome 2 associated with cryptic duplication of 2q14 and deletion of 2q37 in a patient with autism.</article-title>
                <source>Am J Med Genet A</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>2346</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">20684015</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.drake.2009.5985">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drake</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruteshouser</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Natrajan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harbor</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wegert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gessler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pritchard-Jones</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grundy</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dome</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huff</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldred</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.</article-title>
                <source>Clin Cancer Res</source>
                <year>2009</year>
                <volume>15</volume>
                <fpage>5985</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">19789318</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.falk.2007.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Falk</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casas</surname>
                    <given-names>KA</given-names>
                  </name>
                </person-group>
                <article-title>Chromosome 2q37 deletion: clinical and molecular aspects.</article-title>
                <source>Am J Med Genet C Semin Med Genet.</source>
                <year>2007</year>
                <volume>145C</volume>
                <fpage>357</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">17910077</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.felder.2009.952">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Felder</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radlwimmer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mincheva</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000f6;dt</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beyer</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuster</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;lte</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schm&#x000f6;tzer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klauck</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poustka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poustka</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>FARP2, HDLBP and PASK are downregulated in a patient with autism and 2q37.3 deletion syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2009</year>
                <volume>149A</volume>
                <fpage>952</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19365831</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.fernandezrebollo.2009.711">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez-Rebollo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Bouzas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotarelo-P&#x000e9;rez</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruibal</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Nanclares</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casta&#x000f1;o</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Nanclares</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <article-title>Two cases of deletion 2q37 associated with segregation of an unbalanced translocation 2;21: choanal atresia leading to misdiagnosis of CHARGE syndrome.</article-title>
                <source>Eur J Endocrinol</source>
                <year>2009</year>
                <volume>160</volume>
                <fpage>711</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19332529</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.internationalmole.2001.570">
              <element-citation publication-type="journal">
                <publisher-name>International Molecular Genetic Study of Autism Consortium</publisher-name>
                <article-title>A genome-wide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p.</article-title>
                <source>Am J Hum Genet</source>
                <year>2001</year>
                <volume>69</volume>
                <fpage>570</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11481586</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.jacquemont.2006.843">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jacquemont</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanlaville</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raoul</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Blois</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prieur</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colleaux</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philippe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders.</article-title>
                <source>J Med Genet</source>
                <year>2006</year>
                <volume>43</volume>
                <fpage>843</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16840569</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.johnson.2003.984">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kan</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldridge</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trembath</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roche</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esnouf</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkie</surname>
                    <given-names>AO</given-names>
                  </name>
                </person-group>
                <article-title>Missense mutations in the homeodomain of HOXD13 are associated with brachydactyly types D and E.</article-title>
                <source>Am J Hum Genet</source>
                <year>2003</year>
                <volume>72</volume>
                <fpage>984</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">12649808</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.jones.2011.2221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stiller</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bown</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Wilms tumor incidence in children with 2q terminal deletions: a cohort study.</article-title>
                <source>Am J Med Genet A</source>
                <year>2011</year>
                <volume>155A</volume>
                <fpage>2221</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">21815249</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.kitsioutzeli.2007.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kitsiou-Tzeli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sismani</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioannides</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bashiardes</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ketoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touliatou</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolialexi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mavrou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanavakis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patsalis</surname>
                    <given-names>PC</given-names>
                  </name>
                </person-group>
                <article-title>Array-CGH analysis and clinical description of 2q37.3 de novo subtelomeric deletion.</article-title>
                <source>Eur J Med Genet</source>
                <year>2007</year>
                <volume>50</volume>
                <fpage>73</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17194633</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.lacbawan.2006.1">
              <mixed-citation publication-type="confproc">Lacbawan F, Jones M, Dutra A, Chandrasekharappa S, Doherty ES. Chromosome 2q37 deletion syndrome: defining clinical features. Abstract 869. New Orleans, LA: American Society of Human Genetics Annual Meeting. 2006.</mixed-citation>
            </ref>
            <ref id="del2q37_2.REF.lacbawan.2005.1">
              <mixed-citation publication-type="confproc">Lacbawan FL, Domingo DL, Jones M, Hart TC, Chandrasekharappa S, Doherty ES. Molecular breakpoint-phenotype analysis and stereophotogrammetry of chromosome 2q37 deletion syndrome. Abstract 182. American College of Medical Genetics Meeting. 2005.</mixed-citation>
            </ref>
            <ref id="del2q37_2.REF.lehman.2001.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lehman</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaleski</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanger</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adickes</surname>
                    <given-names>ED</given-names>
                  </name>
                </person-group>
                <article-title>Holoprosencephaly associated with an apparent isolated 2q37.1--&#x0003e;2q37.3 deletion.</article-title>
                <source>Am J Med Genet</source>
                <year>2001</year>
                <volume>100</volume>
                <fpage>179</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11343300</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.lukusa.2004.293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lukusa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeesch</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holvoet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Deletion 2q37.3 and autism: molecular cytogenetic mapping of the candidate region for autistic disorder.</article-title>
                <source>Genet Couns</source>
                <year>2004</year>
                <volume>15</volume>
                <fpage>293</fpage>
                <lpage>301</lpage>
                <pub-id pub-id-type="pmid">15517821</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.masumoto.2006.213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Masumoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taguchi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Oesophageal atresia with a terminal deletion of chromosome 2q37.1.</article-title>
                <source>Clin Dysmorphol</source>
                <year>2006</year>
                <volume>15</volume>
                <fpage>213</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16957475</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.morris.2012.2015">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Etoubleau</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourthoumieu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynaud-Perrine</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laroche</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebbar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yardin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsea</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>Dose dependent expression of HDAC4 causes variable expressivity in a novel inherited case of brachydactyly mental retardation syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>2015</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">22753018</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.morrow.2008.218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morrow</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoo</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flavell</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>TK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukaddes</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balkhy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gascon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashmi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Saad</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ware</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joseph</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenblatt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleason</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ertelt</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Apse</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Partlow</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barry</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markianos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferland</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Identifying autism loci and genes by tracing recent shared ancestry.</article-title>
                <source>Science.</source>
                <year>2008</year>
                <volume>321</volume>
                <fpage>218</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">18621663</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.nie.2002.48965">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nie</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanley</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stauffer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacques</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takei</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Randazzo</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>AGAP1, an endosome-associated, phosphoinositide-dependent ADP-ribosylation factor GTPase-activating protein that affects actin cytoskeleton.</article-title>
                <source>J Biol Chem</source>
                <year>2002</year>
                <volume>277</volume>
                <fpage>48965</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">12388557</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.olson.1995.305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Olson</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breslow</surname>
                    <given-names>NE</given-names>
                  </name>
                </person-group>
                <article-title>Non-11p constitutional chromosome abnormalities in Wilms' tumor patients.</article-title>
                <source>Med Pediatr Oncol</source>
                <year>1995</year>
                <volume>24</volume>
                <fpage>305</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">7700182</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.ravnan.2006.478">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ravnan</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tepperberg</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papenhausen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamb</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedrick</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eash</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ledbetter</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <article-title>Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities.</article-title>
                <source>J Med Genet</source>
                <year>2006</year>
                <volume>43</volume>
                <fpage>478</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">16199540</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.reddy.1999.460">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reddy</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flannery</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <article-title>Microdeletion of chromosome sub-band 2q37.3 in two patients with abnormal situs viscerum.</article-title>
                <source>Am J Med Genet</source>
                <year>1999</year>
                <volume>84</volume>
                <fpage>460</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10360400</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.reddy.2005.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reddy</surname>
                    <given-names>KS</given-names>
                  </name>
                </person-group>
                <article-title>Cytogenetic abnormalities and fragile-X syndrome in autism spectrum disorder.</article-title>
                <source>BMC Med Genet</source>
                <year>2005</year>
                <volume>6</volume>
                <fpage>3</fpage>
                <pub-id pub-id-type="pmid">15655077</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.shrimpton.2004.537">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shrimpton</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braddock</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomson</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoo</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <article-title>Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype.</article-title>
                <source>Clin Genet</source>
                <year>2004</year>
                <volume>66</volume>
                <fpage>537</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">15521982</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.smith.2001.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escamilla</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filipek</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bocian</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Modahl</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flodman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spence</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR.</article-title>
                <source>Cytogenet Cell Genet</source>
                <year>2001</year>
                <volume>94</volume>
                <fpage>15</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">11701947</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.sogaard.2005.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sogaard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tumer</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hjalgrim</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnemann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friis</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ledaal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedersen</surname>
                    <given-names>VF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baekgaard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tommerup</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cingoz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brondum-Nielsen</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Subtelomeric study of 132 patients with mental retardation reveals 9 chromosomal anomalies and contributes to the delineation of submicroscopic deletions of 1pter, 2qter, 4pter, 5qter and 9qter.</article-title>
                <source>BMC Med Genet</source>
                <year>2005</year>
                <volume>6</volume>
                <fpage>21</fpage>
                <pub-id pub-id-type="pmid">15904506</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.vankarnebeek.2002.546">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Karnebeek</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koevoets</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sluijter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bijlsma</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeets</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redeker</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoovers</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Prospective screening for subtelomeric rearrangements in children with mental retardation of unknown aetiology: the Amsterdam experience.</article-title>
                <source>J Med Genet.</source>
                <year>2002</year>
                <volume>39</volume>
                <fpage>546</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12161591</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.villavicenciolorini.2012.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Villavicencio-Lorini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klopocki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trimborn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koll</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horn</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic variant of Brachydactyly-mental retardation syndrome in a family with an inherited interstitial 2q37.3 microdeletion including HDAC4.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2012</year>
                <pub-id pub-id-type="pmid">23188045</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.viotszoboszlai.1998.278">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Viot-Szoboszlai</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prieur</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couturier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zucker</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henry</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Wilms' tumor and gonadal dysgenesis in a child with the 2q37.1 deletion syndrome.</article-title>
                <source>Clin Genet</source>
                <year>1998</year>
                <volume>53</volume>
                <fpage>278</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">9650765</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.wassink.2005.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wassink</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piven</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieland</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frantz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartlett</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goedken</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Childress</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spence</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheffield</surname>
                    <given-names>VC</given-names>
                  </name>
                </person-group>
                <article-title>Evaluation of the chromosome 2q37.3 gene CENTG2 as an autism susceptibility gene.</article-title>
                <source>Am J Med Genet B Neuropsychiatr Genet</source>
                <year>2005</year>
                <volume>136B</volume>
                <fpage>36</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">15892143</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.williams.2010.219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldred</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Der Kaloustian</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halal</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gowans</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLeod</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zondag</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toriello</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magenis</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsea</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.</article-title>
                <source>Am J Hum Genet</source>
                <year>2010</year>
                <volume>87</volume>
                <fpage>219</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">20691407</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.wilson.1995.400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leverton</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oude Luttikhuis</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oley</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flint</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolstenholme</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duckett</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrow</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Read</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trembath</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <article-title>Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37.</article-title>
                <source>Am J Hum Genet</source>
                <year>1995</year>
                <volume>56</volume>
                <fpage>400</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">7847374</pub-id>
              </element-citation>
            </ref>
            <ref id="del2q37_2.REF.wolff.2002.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolff</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clifton</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karr</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charles</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Pilot assessment of the subtelomeric regions of children with autism: detection of a 2q deletion.</article-title>
                <source>Genet Med</source>
                <year>2002</year>
                <volume>4</volume>
                <fpage>10</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11839952</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="del2q37_2.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="del2q37_2.Acknowledgments">
          <title>Acknowledgments</title>
          <p>We are indebted to the affected individuals we work with and their families. This work was supported by the Division of Intramural Research, National Human Genome Research Institute, and National Institutes of Health. </p>
        </sec>
        <sec id="del2q37_2.Author_History">
          <title>Author History</title>
          <p>Emily S Doherty, MD, FAAP, FACMG (2007-present)Felicitas L Lacbawan, MD, FCAP, FACMG (2007-present)Benjamin D Solomon, MD; National Human Genome Research Institute (2007-2012)</p>
        </sec>
        <sec id="del2q37_2.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>31 January 2013 (cd) Revision: additional information on the role of <italic toggle="yes">HDAC4</italic></p>
            </list-item>
            <list-item>
              <p>9 August 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 May 2007 (me) Review posted live </p>
            </list-item>
            <list-item>
              <p>21 March 2007 (esd) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
